References
- Burns M J. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol 2001; 39: 1–14, [PUBMED], [INFOTRIEVE]
- Bhana N, Foster R H, Olney R, Plosker G L. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 2001; 61: 111–161, [PUBMED], [INFOTRIEVE]
- Davis M P, Dickerson E D. Olanzapine: another psychotropic?. Am J Hospice Palliat Care 2001; 18: 129–132
- Bever K A, Perry P J. Olanzapine: a serotonin‐dopamine‐receptor antagonist for antipsychotic therapy. Am J Health‐Syst Pharm 1998; 55: 1003–1016
- Selva K A, Scott S M. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J Pediatr 2001; 138: 936–938, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bonanno D G, Davydov L, Botts S R. Olanzapine‐induced diabetes mellitus. Ann Pharmacother 2001; 35: 563–565, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rigalleau V, Gatta B, Bonnaud S, Masson M, Bourgeois M L, Vergnot V, Gin H. Diabetes as a result of atypical anti‐psychotic drugs—a report of three cases. Diabet Med 2000; 17: 484–486, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Biswas P N, Wilton L V, Pearce G L, Freemantle S, Shakir S A.W. The pharmacovigilance of olanzapine: results of a post‐marketing surveillance study on 8858 patients in England. J Psychopharmacol 2001; 15: 265–271
- Wyderski R J, Starrett W G, Abou‐Saif A. Fatal status epilepticus associated with olanzapine therapy. Ann Pharmacother 1999; 33: 787–789, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lee J W, Crismon M L, Dorson P G. Seizure associated with olanzapine. Ann Pharmacother 1999; 33: 554–556, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stanfield S C, Privette T. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. J Emerg Med 2000; 19: 355–357, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Benedetti F, Cavallaro R, Smeraldi E. Olanzapine‐induced neutropenia after clozapine‐induced neutropenia. Lancet 1999; 354: 567, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Naumann R, Felber W, Heilemann H, Reuster T. Olanzapine‐induced agranulocytosis. Lancet 1999; 354: 566–567, [PUBMED], [INFOTRIEVE], [CROSSREF]
- O'Malley G F.O, Seifert S, Heard K, Daly F, Dart R C. Olanzapine overdose mimicking opioid intoxication. Ann Emerg Med 1999; 34: 279–281, [PUBMED], [INFOTRIEVE]
- Johal B K, Shelly M P. Olanzapine overdose. Anaesthesia 2000; 55: 929, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cohen L G, Fatalo A, Thompson B T, Di Centes Bergeron G, Flood J G, Poupolo P R. Olanzapine overdose with serum concentrations. Ann Emerg Med 1999; 34: 275–278, [PUBMED], [INFOTRIEVE]
- Bosch R F, Baumbach A, Bitzer M, Erley C M. Intoxication with olanzapine. Am J Psych 2000; 157: 304–305, [CROSSREF]
- Karch F E, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–254, [PUBMED], [INFOTRIEVE]
- Persson H E, Sjoberg G K, Haines J A, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 36: 205–213, [PUBMED], [INFOTRIEVE]
- Catalano G, Cooper D S, Catalano M C, Butera A S. Olanzapine overdose in an 18‐month‐old child. J Child Adolesc Psychopharmacol 1999; 9: 267–271, [PUBMED], [INFOTRIEVE]
- Fogel J, Diaz J E, Camden N J. Olanzapine overdose. Ann Emerg Med 1998; 32: 275–276, [PUBMED], [INFOTRIEVE]
- Gardner D M, Milliken J, Serdar M D. Olanzapine overdose. Am J Psychiatry 1999; 156: 1118–1119, [PUBMED], [INFOTRIEVE]
- Dobrusin M, Lokshin P, Belmaker R H. Acute olanzapine overdose. Hum. Psychopharmacol Clin Exp 1999; 14: 355–356, [CROSSREF]
- Elian A A. Fatal overdose of olanzapine. Forensic Sci Int 1998; 91: 231–235, [PUBMED], [INFOTRIEVE], [CROSSREF]